InsiderTrades

Form 4 for G Genpact LTD

Accepted 2025-09-15 00:00:00 ET · period of report 2025-09-12 · accession 0001408238-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-09-15 2025-09-12 G Mehta Piyush SVP, CHRO S - Sale+OE $42.58 -76.9K 161.8K -32% -$3.27M
D 2025-09-15 2025-09-12 G Mehta Piyush SVP, CHRO M - OptEx $31.50 +50.0K 211.8K +31% +$1.57M
D 2025-09-15 2025-09-12 G Mehta Piyush SVP, CHRO M - OptEx $0.00 -50.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2025-09-12 S D 26,902 $42.58 134,880 D — — (F3) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.70. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
2 Common Common Shares 2025-09-12 M A 50,000 $31.50 211,782 D — — (F1) Includes 284 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 13, 2025. The reporting person currently holds a total of 10,222 shares under the ESPP.
3 Common Common Shares 2025-09-12 S D 50,000 $42.58 161,782 D — — (F2) The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $42.42 to $42.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
4 Derivative Employee Stock Option (Right to Buy) 2025-09-12 M D 50,000 $0.00 0 D $31.50 · — to 2028-04-01 50,000 Common Shares (F4) The option vested 50% on April 2, 2021 and the remainder on April 2, 2023.